BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL

NCT07678229 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Extranodal NK/T-cell Lymphoma

Interventions

DRUG: GELAD regimen
DRUG: MEDA regimen
DRUG: LEAP regimen
DRUG: High-dose methotrexate
PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation

Sponsor

Rong Tao